Extrait

To compare the proportions of people still taking adalimumab or etanercept one year after starting treatment for rheumatoid arthritis. Our objective is to determine whether adalimumab is inferior to etanercept for the treatment of rheumatoid arthritis.

Critère d'inclusion

• Rheumatoid Arthritis

Liens

• ictrp
• euctr